ARCHIVES

FDA Considering Ways To Improve Process Of Secondary Approvals Of Cancer Drugs

This article is from The Cancer Letter archive.

Vol. 17 No. 42 | November 1, 1991

Download PDF Visit The Full Archive

Related Articles

NCI Director Declines To Fund P-4 Breast Cancer Chemoprevention Trial.

June 22, 2007

Bill Pressures HCFA To Launch Project On Reimbursement for Cancer Trials

July 26, 1996

NCI Begins Ovarian Cancer Trial To Build Blood Samples

October 28, 2005

FDA Committee Okays High Dose Methotrexate, Mitxantrone In ANL; reverse Breast Cancer Vote

December 11, 1987

In Brief: Children’s Hospital Of Boston Names Pizzo Physician-In-chief; Lynch Wins Bristol Award

March 22, 1996

NCI Support Crucial for Israel cancer Studies; Weizmann Top Recipient

June 17, 1977